Enzo Biochem Inc. (ENZ)
Medical Uses of Biotechnology in Testing In Treatment include: i) Enzyme replacement therapy which means producing an enzyme that is administered to the person as a medicine, and which takes over the function of a similar enzyme that the person's own cells are unable to produce in the right quantity, as a result of a genetic fault; ii) Gene therapy which means using genes as medicine, for a person whose own genes have a fault in them. It involves introducing a new gene into the person to compensate for the incorrect expression of their own gene, and may also involve other action to stimulate an inactive gene, or restrict an overactive one; iii) Stem cell therapy which means using stem cells, which are special cells that have properties that enable them to grow into a variety of different tissue types, and using them to replace or supplement particular tissue in a person with a genetic condition or health problem; and iv) Xeno-transplantation of cells from animals to humans which means taking tissue from other animal species and transplanting it into a person, to replace or supplement particular tissue that is affected by a genetic condition. This could also be used for other purposes such as heart valve replacements or skin grafts.

Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.

Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.

The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D'Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.

Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary's operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo's presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.

For more information please visit: www.enzo.com

*******************************

Cleantech Transit, Inc. (CLNO)
Cleantech Transit, Inc. is in the business of producing and conserving power. Cleantech Transit produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. Cleantech Transit's goal is to use innovative technologies to reduce electricity consumption and dependence on carbon based energy. Cleantech Transit, Inc. was founded in 2006 and is based in Scottsdale, Arizona.

Biomass is useful in describing such natural and biological materials which are commonly used in the production of electricity. Biomass includes different types of fuels from garbage, landfill and ethanol. The production of electricity from biomass is used to power different things from industries to homes.

The common types of biomass can be found in many forms. Products of wood things similar to lawn clippings, leftover wood scraps from lumber production, wood chips, leaves as well as dead tress are also one such form. People use garbage products to burn as fuel or landfill gases that are formed when garbage rots. The fossil fuel replacements which is the Ethanol and biodiesel are made from either corn or biomass fuel for the purpose of producing electricity.









Read the full article and the disclaimer atennyotcstock.com/?p=17448